INTRALIPID 20%

Valsts: Indonēzija

Valoda: indonēziešu

Klimata pārmaiņas: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Aktīvā sastāvdaļa:

SOYBEAN OIL

Pieejams no:

FRESENIUS KABI COMBIPHAR - Indonesia

SNN (starptautisko nepatentēto nosaukumu):

SOYBEAN OIL

Deva:

200 G/1000 ML

Zāļu forma:

INFUS

Vienības iepakojumā:

BOTOL @ 100 ML

Ražojis:

SINO - SWED Pharmaceutical Corp Ltd - China

Autorizācija datums:

2018-02-27

Produkta apraksts

52010-88-C
COMPOSITION
Fat emulsion 200 mg/ml for infusion.
1000 ml contain : Purified soybean oil 200 g, purified egg
phospholipids 12 g, glycerol (USP) 22 g, sodium hydroxide
to pH approx. 8.0, water for injection to 1000 ml.
PROPERTIES
Intralipid is a fat emulsion for intravenous use containing
fractioned soybean oil emulsified with fractioned egg-yolk
phospholipids. About 60 % of the fatty acids in Intralipid
are essential ones. Particle size and biological properties
are similar to those of natural chylomicrons. The energy
content of Intralipid 10 % is 4.6 MJ (1,100 kcal) per litre,
where Intralipid 20 % has an energy source should be
regarded as an integrated part of Fresenius Kabi complete
programme for intravenous nutrition. The administration
of Intralipid also supplies the requirement of essential
fatty acids.
INDICATIONS
Intralipids is indicated as a part of the intravenous diet for
patients requiring intravenous nutrition.
Preoperative and postoperative nutritional disturbances
in which a large supply of energy is necessary or desirable,
e.g. in order to improve the nitrogen balance.
Nutritional disorders or disturbances of nitrogen balance
due to inadequate or failing intestinal absorption caused
by tumours in the gastrointestinal tract, acute or chronic
intestinal diseases(peritonitis, ulcerative colitis, terminal
ileitis) etc.
Burns.
In extensive burns every additional value of energy
supply as means of reducing the frequently excessive
nitrogen losses. A larger supply of energy also improves
the utilization of orally ingested protein as well as of
infused Vamin.
Intravenously administered fat is also indicated in patients
in whom oral nutrition is inadequate.
Prolonged
unconsciousness,
e.g.
following
cranial
traumata or poisoning in cases where tube feeding is
inappropriate or impossible.
Impaired renal function,
in which condition an adequate
supply of energy is essential to reduce protein breakdown.
Cachexia.
SIDE EFFECTS
In rare cases Intralipid causes a rise in temperature and
chilis. Rises in